Editas Medicine taps former Biogen leader as CEO
February 08, 2021 at 14:55 PM EST
Two years after taking the helm of CEO at Cambridge gene therapy firm Editas Medicine, Cindy Collins is stepping down.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|